Net Cash Provided by (Used in) Operating Activities |
-21.2M |
USD |
-475395% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
21.5M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
1.15M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
258K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.27M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.39M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
1.39M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.08M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
890K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
23.1M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
497K |
USD |
|
Mar 31, 2024 |
Q1 2024 |